MSB mesoblast limited

4.06%

$1.80

" Either that, or a number of these excellent investors were...

First 6 Last

Share
Profile

Follow
ddzx

37,911 Posts.

828

20/11/15

06:25

Post #: 16437859
Share

Originally posted by Fruitbat2 ↑

The mantra that “Australian investors don’t know how to value life sciences companies” appears to have been discredited by Mesoblast’s foray to the Nasdaq.

Or maybe the mantra is right and the Americans do know their valuations.

Either way, to list on the Nasdaq to double a cash runway from three quarters to six quarters, while cutting the total market capitalization in half and killing the Australian share price, seems to be yet another disaster for Australian biotechs who think they need a US listing.

Mesoblast joins the ranks of Alchemia, Benitec, Biota and several others who have listed or attempted to list on the Nasdaq, to the detriment of their shareholders.

According to its last Appendix 4C Quarterly Report, Mesoblast spent $28.1 million for the three months to September 30, 2015 and had $77.8 million in cash.

With the gross proceeds of $95.8 million, the company has a secure 18 month runway, but the price was high with its total market capitalization slashed from $1.2 billion at October 31, 2015 to $658 million today and even lower if you convert the Nasdaq valuation.

Apart from causing the Australian share price to go into free-fall from $3.41 a share before the American adventure, it appears that at least some of the wise, knowledgeable and experienced US life science investors bought the shares at $US8.00 each and were more than happy to dump some of them at prices as low as $US6.51 each, an 18.625 percent loss in two days. Either that, or a number of these excellent investors were always intending to short the stock.

It conjures up a vision of Mesoblast chief executive Prof Silviu Itescu being ushered into the lead brokers board room and being invited to have a whiskey and a cigar while the last details of the $US68.3 million raising were being finalized.

“We’ll be back in a minute. Jest you set yourself there and enjoy the view of Manhattan.”

“... okay, we had a word with the key investors and it’s all hunky dory, Silviu. We’ve got your $68 mill... but the price has dropped from $12 to $8. Hope you don’t mind partner. You better hurry or you’ll miss your flight home.”

“Nice doing business with you.”

The take home messages for ASX-listed biotechs are extremely clear: If you can’t raise funds in Melbourne or Sydney – or even Perth – there’s a reason for it and it is not Australian valuations. And if the price is not right, be prepared to walk away.

Mesoblast fell a further 12 cents or 6.15 percent to $1.83 with 2.6 million shares traded.

David Langsam Editor

Expand

" Either that, or a number of these excellent investors were always intending to short the stock."

looks like that

currently down again on 153,703 volume

if the 'investors" don't mop up the small amount of available stock then their intention is to short it and set it up for a cheap takeover

they are not really 'investors' but, instead, a typical USA-CIA type 'covert operation' (like ISIS)

this is the American way

ask the old CXS; ask AGS; each outmaneuvered by Uncle Sam

Last edited by ddzx: 20/11/15

MSB Price at posting: $1.83 Sentiment: None Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

ASX Market Close: Pretty boring day, but we're back in the 8,600s

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

Unemployment expectations correctly called today's 4.3% rate

BRU

Buru sinks -8% on adjusted Rafael Gas Project timeline aimed to 'reduce risk'

GDM

Great Divide 'rapidly evolving' into commercial miner with first Challenger pour

First 6 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.80		Change 0.070(4.06%)		Mkt cap ! $2.297B

Open	High	Low	Value	Volume
$1.73	$1.80	$1.70	$6.149M	3.505M

Buyers (Bids)

No.	Vol.	Price($)
55	67607	$1.79

Sellers (Offers)

Price($)	Vol.	No.
$1.80	87025	19

View Market Depth

No.	Vol.	Price($)
54	69796	1.790
16	65867	1.785
13	215522	1.780
9	43788	1.775
8	61417	1.770

Price($)	Vol.	No.
1.795	107243	16
1.800	175526	35
1.805	74373	7
1.810	223607	13
1.815	117400	10

Last trade - 15.48pm 17/07/2025 (20 minute delay)

MSB (ASX) Chart

" Either that, or a number of these excellent investors were...

ASX Market Close: Pretty boring day, but we're back in the 8,600s

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

Unemployment expectations correctly called today's 4.3% rate

Buru sinks -8% on adjusted Rafael Gas Project timeline aimed to 'reduce risk'

Great Divide 'rapidly evolving' into commercial miner with first Challenger pour

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

" Either that, or a number of these excellent investors were...

Top Stories

ASX Market Close: Pretty boring day, but we're back in the 8,600s

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

Unemployment expectations correctly called today's 4.3% rate

Buru sinks -8% on adjusted Rafael Gas Project timeline aimed to 'reduce risk'

Great Divide 'rapidly evolving' into commercial miner with first Challenger pour

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News